Moore, Hunter B <br/><br/>
Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?  [electronic resource] 

 -  Journal of the American College of Surgeons  07 2019 
 - 92-101 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1879-1190 
<br/><br/><label>Standard No.: </label>10.1016/j.jamcollsurg.2019.03.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antifibrinolytic Agents--pharmacology<br/>Biomarkers--blood<br/>Female<br/>Fibrin Clot Lysis Time<br/>Fibrin Fibrinogen Degradation Products--drug effects<br/>Fibrinogen--metabolism<br/>Fibrinolysis--drug effects<br/>Follow-Up Studies<br/>Hemorrhage--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Thrombelastography--methods<br/>Tranexamic Acid--pharmacology<br/>Trauma Severity Indices<br/>Wounds and Injuries--blood